investigational therapeutics | sciencenewsnet.in

Breaking News

Interplay between mesenchymal stem cells and macrophages: Promoting bone tissue repair

Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19

Biological scaffold as potential platforms for stem cells: Current development and applications in wound healing

Effects of high glucose and severe hypoxia on the biological behavior of mesenchymal stem cells at various passages

Gossypol acetic acid regulates leukemia stem cells by degrading LRPPRC via inhibiting IL-6/JAK1/STAT3 signaling or resulting mitochondrial dysfunction

Expansion of human umbilical cord derived mesenchymal stem cells in regenerative medicine

Unveiling the role of hypoxia-inducible factor 2alpha in osteoporosis: Implications for bone health

Reveal more mechanisms of precondition mesenchymal stem cells inhibiting inflammation

Adipose-derived regenerative therapies for the treatment of knee osteoarthritis

Barcodes expand range of high-resolution sensor

26 Apr, 2024

Focus Fund and MD Anderson launch investment fund to support promising investigational cancer therapies in early-stage clinical trials

October 20, 2020 sarah JonasAnnouncement

The Focus Fund GP, LLC, in partnership with The University of Texas MD Anderson Cancer Center, has launched Cancer Focus Fund, LP, an oncology-focused investment fund designed to support the advancement of compelling investigational cancer therapies from late preclinical development through Phase I and Phase Ib/II clinical trials.

Baylor Scott & White Research Institute Expands Efforts in the Fight Against COVID-19

July 24, 2020 sarah JonasFeature

As the global response to the SARS-COV-2 virus that causes COVID-19 approaches 200 days, Baylor Scott & White Research Institute, the research and development arm of Baylor Scott & White Health, is accelerating its pace of bringing clinical trials online.

Baylor Scott & White Research Institute continues to mobilize staff and resources, including components needed to integrate critical patient-safety measures at every participating site within the Baylor Scott & White system for industry sponsored drug trials, investigator-initiated drug trials and research studies, and observational and data studies designed to help increase knowledge around case trends, viral epidemiology, and care best practices.